Latest News for: igc

Edit

IGC Pharma Advances Caregiver Engagement as Phase 2 CALMA Trial Advances Final Enrollment Phase (IGC Pharma Inc)

Public Technologies 28 Apr 2026
). The text version of this document is not available ... IGC Pharma Inc.
Edit

IGC Pharma Advances Caregiver Engagement as Phase 2 CALMA Trial Advances Final Enrollment Phase

The Milton Standard Journal 28 Apr 2026
Outreach initiative supports awareness of agitation and patient engagement as enrollment approaches completion ....
Edit

IGC Pharma Adds Kerwin Medical Center in Dallas to Phase 2 CALMA Trial as Enrollment ...

Times Argus 25 Apr 2026
Behavioral neurology expertise and expanded patient access support final phase of recruitment in Alzheimer's agitation study ....
Edit

IGC Pharma Secures Psilocybin Research Authorization, Expanding Focus on Neuropsychiatric Symptoms in Dementia

Rutland Herald 25 Apr 2026
Authorization provides regulated capability to evaluate emerging therapeutic approaches alongside Phase 2 CALMA trial approaching completion ....
Edit

IGC pares global grain output projections for 2026-27 by 3 million tonnes

Business Line 24 Apr 2026
Concerns over fertiliser affordability, usage due to war in West Asia weighs on the production estimates ....
Edit

SHKP welcomes Banco Santander as first tenant moving into IGC (Sun Hung Kai Properties Ltd)

Public Technologies 24 Apr 2026
Sun Hung Kai Properties Limited (SHKP) is delighted to welcome global bank Banco Santander as the first tenant to move into the International Gateway Centre (IGC) in West Kowloon ... Their move to IGC ...
Edit

IGCS International Announces Strategic Equity Investment by Lacks Enterprises

Quad-City Times 23 Apr 2026
DALLAS, April 22, 2026 /PRNewswire/ -- IGCS ...
Edit

Material Agreement, Financial Obligation, Private Placement (Form 8-K) (IGC Pharma Inc)

Public Technologies 20 Apr 2026
On April 10, 2026, IGC Pharma, Inc. ("IGC" or the "Company") executed a Securities Purchase Agreement (the "Purchase ... In addition to it, IGC Pharma, Inc ... IGC Pharma Inc.
Edit

IGC Pharma Reaches 80% Enrollment in Phase 2 CALMA Trial, Entering Final Phase Ahead of Enrollment Completion and Data Readout

News-Press Now 14 Apr 2026
(NYSE American.IGC) ("IGC" or ...
Edit

IGC Pharma Reaches 80% Enrollment in Phase 2 CALMA Trial, Entering Final Phase Ahead of ...

Hastings Tribune 14 Apr 2026
(NYSE American.IGC) ("IGC" or the "Company") today ...
Edit

New to The Street Broadcasts on Bloomberg Television at 6:30 PM EST Featuring IGC Pharma ...

Reflector 11 Apr 2026
Special continuing M&A Segment with Senior M&A Partner at Sullivan & Cromwell LLP, Frank Aquila ... .
Edit

Ascendiant Capital Markets Raises IGC Pharma Price Target to $5.25, Citing Clinical Progress and Upcoming Catalysts

Corsicana Daily Sun 09 Apr 2026
(NYSE American.IGC) ("IGC" or the "Company"), a ...
Edit

IGC Pharma Adds Tandem Clinical Research to the CALMA Trial for Agitation in Alzheimer's Disease

Times Argus 07 Apr 2026
(NYSE American.IGC) ("IGC" or the "Company"), a ...
Edit

IGC Pharma Adds Tandem Clinical Research to the CALMA Trial for Agitation in Alzheimer

News-Press Now 07 Apr 2026
(NYSE American.IGC) ("IGC" or the ...
Edit

Statement of Changes in Beneficial Ownership (Form 4) (IGC Pharma Inc)

Public Technologies 06 Apr 2026
) FORM 4. Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue ... See Instruction 10 ... IGC Pharma, Inc. [IGC] 5 ... (3) Each restricted stock unit represents a right to receive one share of IGC common stock ... IGC Pharma Inc.

Article Search

tools
×
×
×
×